Evidence map›Paper›PMID 31762739›Full record

ArticleCase reports in dermatology

Erythema Gyratum Repens in Long-Term Smoker.

Andrew P Sauvageau, Jacob Mojeski, Thomas W Fiorica, Craig C Miller

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Erythema gyratum repens after COVID-19.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Andrew P SauvageauJacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Jacob MojeskiJacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Thomas W FioricaJacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.
Craig C MillerNiagara Dermatology Associates, Lewiston, New York, USA.
Jacobs (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erythema gyratum repens (EGR) is a rare paraneoplastic skin condition characterized by the eruption of expanding, concentric, erythematous patches and plaques. The condition may precede a symptomatic appearance of internal malignancy, and therefore provides a unique opportunity to prevent additional morbidity and mortality secondary to undetectable cancer growth. We report the case of a 71-year-old female patient clinically diagnosed with EGR and subsequently diagnosed with otherwise asymptomatic adenocarcinoma of the lung.

Indexed as

Erythema gyratum repensParaneoplastic skin conditionPolycyclic erythematous rashes

Identifiers

PMID31762739
PMCPMC6873075
OpenAlexW2978031424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.